PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell GrowthYun-Rong Zhu(Jiangyin People's Hospital), Yunqing Zhang(Jiangyin People's Hospital)Frontiers in OncologyJuly 14, 202110.3389/fonc.2021.659181Cited by 13SaveCiteExport RISWatch citationsRelated PapersThe anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models|Oncotarget|2016|47